Fresenius Medical Care | FME - Current Liabilities


Fresenius Medical Care reported EUR7.91B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Akzo Nobel EUR 4.37B 56M Sep/2026
Alcon AG USD 3.17B 163M Jun/2026
AstraZeneca USD 31.27B 286M Sep/2026
Bayer EUR 29.4B 2.87B Sep/2026
Beiersdorf EUR 3.72B 209M Jun/2026
DaVita Healthcare Partners USD 2.89B 31.34M Sep/2026
Demant DKK 12.42B 5B Jun/2026
E.ON EUR 30.52B 2.56B Sep/2026
Essilor EUR 12.64B 490M Jun/2026
Fresenius EUR 8.08B 986M Sep/2026
Fresenius Medical Care EUR 7.91B 727.93M Sep/2026
Genmab DKK 1.14B 38M Jun/2026
Getinge SEK 12.03B 3.01B Jun/2026
Givaudan CHF 2.35B 422M Dec/2025
GlaxoSmithKline GBP 20.72B 814M Sep/2026
GN Store Nord DKK 10.82B 4.86B Sep/2026
GRIFOLS EUR 2.3B 59M Sep/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 8.96B 833M Sep/2026
Novartis USD 32.52B 777M Sep/2026
Philips EUR 7.91B 485M Sep/2026
Roche Holding CHF 28.85B 846M Jun/2026
RWE EUR 43.53B 12.71B Sep/2026
Sanofi EUR 29.77B 2.16B Sep/2026
SAP EUR 19.11B 624M Sep/2026
Smith & Nephew USD 2.05B 510M Jun/2026